SULZER MEDICA ENTERING SPINAL SURGERY MARKET VIA SPINE-TECH ACQUISITION; $595 MIL. CASH TENDER OFFER IS ROUGHLY TEN TIMES BAK DEVELOPER's ANNUAL SALES VOLUME
This article was originally published in The Gray Sheet
Executive Summary
Sulzer Medica is paying a substantial premium to enter a high-growth segment of the orthopedics product market -- spinal surgery -- with the $595 mil. acquisition of Spine-Tech. The $52 per share tender offer, announced Dec. 16 and approved by the boards of both companies, represents a 14.3% premium to Spine-Tech's Dec. 15 closing price of 45-1/2.
You may also be interested in...
Split Rock Prepped To Invest In Medical Device Realm After Financing
Split Rock Partners expects to invest the majority of the $275 mil. it has raised from institutional investors into medical device start-up companies, according to Managing Director Dave Stassen
Split Rock Prepped To Invest In Medical Device Realm After Financing
Split Rock Partners expects to invest the majority of the $275 mil. it has raised from institutional investors into medical device start-up companies, according to Managing Director Dave Stassen
Reimbursement, Sales Critical For IPOs As Markets Reopen To Device Firms
"Reimbursement clarity" is essential for device firms in gaining investor confidence in the public equity market, Jeffrey Hoffman, health technology investment banker with U.S. Bancorp Piper Jaffray, emphasized at the recent Frost & Sullivan 5th Annual Medical Devices and Diagnostics Industry Conference in San Francisco.